Skip to main content
TipRanks
Go Ultimate75% OFF

Paul Lytle Insider Profile

4 Followers

Paul Lytle, CFO at Actuate Therapeutics, Inc., holds ― shares in Actuate Therapeutics, Inc. (Ticker: ACTU), holds 1.64M shares in Mosaic ImmunoEngineering (Ticker: CPMV), holds 112.87K shares in Avid Bioservices (Ticker: CDMO).

Paul Lytle's Trading History

CPMV
Mosaic ImmunoEngineering
Jan 29, 2021EVP & CFO, Director, Ten Percent OwnerUninformative Buy―$98.48K
CDMO
Avid Bioservices
Apr 28, 2017―Uninformative Buy10.10K$1.41M
ACTU
Actuate Therapeutics, Inc.
―CFO――

You May Also Like

Paul Lytle insider profile FAQ

What is the percentage of profitable transactions made by Paul Lytle?
The percentage of profitable transactions made by Paul Lytle is 0%.
What is the average return per transaction made by Paul Lytle?
The average return per transaction made by Paul Lytle is -19.30%.
What stocks does Paul Lytle hold?
Paul Lytle holds: ACTU, CDMO, CPMV stocks.
What was Paul Lytle's most profitable transaction?
Paul Lytle’s most profitable transaction was an Informative Buy of CDMO stock on September 24, 2010. The return on the trade was -16.70%.
What is Paul Lytle's role in Actuate Therapeutics, Inc.?
Paul Lytle's role in Actuate Therapeutics, Inc. is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.